Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 560 results found. Search for [ USFDA ]

Results 1 to 21 of 560
E Kumar Sharma
New Delhi, August 24, 2018
The Indian GDP hardly has any implication on the Indian IT industry, from a business and growth perspective, since it is an export-led sector.


BusinessToday.In
August 14, 2018
The Sun Pharma stock closed 6.91% or 38.90 points higher to 601 level on the BSE today. The stock which closed at 562 level yesterday rose 46 points or 8.05% to an intra day high of 608 level on the BSE.


PB Jayakumar
New Delhi, August 2, 2018
Of the Rs 1434 crore overall revenues from exports in FY18, the USA contributed Rs 194 crore for Ajanta with a five per cent growth over the previous year.


BusinessToday.In
July 16, 2018
The Dr Reddy's stock fell up to 10.61% or 246 points to 2,071.50 level. The stock closed 9.85% or 228 points lower at 2089.15 on the BSE.


E Kumar Sharma
New Delhi, June 19, 2018
It wants to focus on India and other emerging markets, while at some stage, perhaps sometime in 2019, it may also look at a foray into the US market. It already has an office in Boston and is scouting for a partner in the US.


PTI
June 15, 2018



BusinessToday.I0n
June 15, 2018
The stock has been gaining for the last eight days and has risen 20.08% in the period. It opened with a gain of 2.23% today. The stock has gained every month in the last seven months and has generated 20.02% returns in the period.


PTI
June 14, 2018



E Kumar Sharma
New Delhi, June 13, 2018
The development is a hugely positive development both for Sun Pharma and for Indian pharma. From a sentiment perspective, it is significant given that the company has been finally able to get its facility cleared after three years.


PTI
June 12, 2018



PTI
June 11, 2018



BusinessToday.In
June 11, 2018
\"The company has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Bupropion Hydrochloride tablets,\" Alembic Pharmaceuticals said in a BSE filing.


PTI
June 8, 2018



BusinessToday.In
June 8, 2018
VAI status means that though objectionable conditions were found at the plant, the issues do not justify further regulatory action and any corrective action is left to the FDA to take voluntarily.


PTI
June 8, 2018



BusinessToday.In
June 5, 2018
The stock of bio-pharmaceutical firm hit 695 level in early trade rising 6.25% on the BSE.


PTI
June 4, 2018



PTI
June 2, 2018



E Kumar Sharma
New Delhi, June 1, 2018
USFDA describes 'congenital aniridia' as \"a rare genetic disorder in which the iris is completely or partially absent. In a first, USFDA has recently approved the \"first stand-alone prosthetic iris\"


PTI
May 28, 2018



PAGES 1 OF 28  12345